Food Stamp Program Sample Clauses

Food Stamp Program. (i) Discrimi- nation by a State agency in certifying households as eligible for the Program. (ii) Segregation or other discrimina- tion in the manner in which or the times at which eligible households are issued food coupons.
View SourceView Similar (2)
Food Stamp Program. A food assistance program governed by FNS that helps low- income people buy the food they need for good health. The program is operated under the authority of the Food Stamp Act of 1964, as amended.
View Source
Food Stamp Program. In an effort to achieve compatibility with the CRDP, the CDSS Food Stamp Program Bureau intends to seek waivers necessary to allow for participation in the project. These waivers will address the differences between the income and resource reporting thresholds of the CalWORKs and Food Stamp Programs. If CDSS is unable to obtain approval of the Food Stamp Program waivers, participating counties may opt out of CRDP. Further information regarding the details of participation, i.e., population to be included (public assistance households, non- assistance households) and other eligibility criteria, will be determined when the representatives from the participating counties meet with Department staff to finalize the CRDP model design. We are currently exploring the inclusion of Medi-Cal Only program cases in the CRDP at county option. These cases would include Medically Indigent and Medically Needy Only cases, except the aged, blind, and disabled (ABD) cases which do not require status reporting. To participate in CRDP counties must: - Guarantee to participate in the demonstration project for one year. Selected counties may opt out of CRDP if CDSS is unable to obtain approval of federal Food Stamp Program waivers. - Operate within current allocations and cover all costs, including expenses associated with data collection and transmission, travel and the county coordinator’s salary and expenses. CDSS will try to minimize data collection requirements. - Designate a single point of contact to work with CDSS staff to develop and implement the demonstration project. This county staff person must be able to meet in Sacramento with CDSS staff and representatives from other counties to exchange ideas and work out the details of the project. The travel expenses will be paid by the county. - Maintain efforts to identify and collect overpayments, including those resulting from this project. - Have the ability to track or identify program participants and gather needed information and provide monthly data to the evaluator no later than 30 days after the end of each month. - Appoint a county coordinator who will fully cooperate with the evaluator and provide all data required by the evaluator in a machine readable format specified by the evaluator. The coordinator’s salary and expenses will be paid by the county. - Provide all necessary data to CDSS for purposes of creating public use data sets. - Provide historical data at the case level on earned income and grants for the ...
View Source
Food Stamp Program. A Federal program designed to permit low income households to obtain a more nutritious diet.
View Source

Related to Food Stamp Program

  • New Application for Licensure Any time after the three-month period has lapsed from the Effective Date of this Agreement and Respondent has paid the Administrative Penalty set forth in Section III, Paragraph 1 of this Order, Respondent may apply for a new mortgage loan originator license or, as applicable, petition for the reinstatement of an MLO Activity Endorsement in any or all of the Participating States with the understanding that each State Mortgage Regulator reserves the rights to fully investigate such application for licensure or petition for reinstatement of an MLO Activity Endorsement and may either approve or deny such application or petition pursuant to the normal process for such licensing or endorsement investigations. No license application or petition described in this paragraph will be denied solely based on the facts, circumstances, or consensual resolution provided for in this Agreement. Respondent further agrees that Respondent must satisfy the Administrative Penalty provision prior to submitting an application for a new mortgage loan originator license or, as applicable, petition for the reinstatement of an MLO Activity Endorsement.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Territorial application This Agreement shall apply, on the one hand, to the territories in which the Treaty establishing the European Community is applied, and under the conditions laid down in that Treaty and, on the other hand, to the territory of the United States.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • Commercialization Plan On a Product by Product basis, not later than sixty (60) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory, the MSC shall prepare and approve a rolling multiyear (not less than three (3) years) plan for Commercializing such Product in the Copromotion Territory (the "Copromotion Territory Commercialization Plan"), which plan includes a comprehensive market development, marketing, sales, supply and distribution strategy for such Product in the Copromotion Territory. The Copromotion Territory Commercialization Plan shall be updated by the MSC at least once each calendar year such that it addresses no less than the three (3) upcoming years. Not later than thirty (30) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory and thereafter on or before September 30 of each calendar year, the MSC shall prepare an annual commercialization plan and budget (the "Annual Commercialization Plan and Budget"), which plan is based on the then current Copromotion Territory Commercialization Plan and includes a comprehensive market development, marketing, sales, supply and distribution strategy, including an overall budget for anticipated marketing, promotion and sales efforts in the upcoming calendar year (the first such Annual Development Plan and Budget shall cover the remainder of the calendar year in which such Product is anticipated to be approved plus the first full calendar year thereafter). The Annual Commercialization Plan and Budget will specify which Target Markets and distribution channels each Party shall devote its respective Promotion efforts towards, the personnel and other resources to be devoted by each Party to such efforts, the number and positioning of Details to be performed by each Party, as well as market and sales forecasts and related operating expenses, for the Product in each country of the Copromotion Territory, and budgets for projected Pre-Marketing Expenses, Sales and Marketing Expenses and Post-Approval Research and Regulatory Expenses. In preparing and updating the Copromotion Territory Commercialization Plan and each Annual Commercialization Plan and Budget, the MSC will take into consideration factors such as market conditions, regulatory issues and competition.